- Latest week
- 17 Jul 2026
- Close
- 535.000000
- Fair value
- 511.381090
- Next-week expectancy
- Negative 20.76%
BEAM Chart Pack
Beam Therapeutics Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, BEAM rose 1.90%, moving from 525.00 to 535.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 5.11 and has softened across the 12-week window. Market Dynamics is 0.71 on the latest week. Next-week expectancy is negative at 20.76% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 535.00
- 12-Week Change
- 1.90%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 20.76%
- Signal Weeks
- 11 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- 5.11
- Market Dynamics
- 0.71
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 535.00
- 12-Week Change
- 1.90%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 20.76%
- Signal Weeks
- 11 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- 5.11
- Market Dynamics
- 0.71
Over the latest 12 completed weeks ending 2026-07-17, BEAM rose 1.90%, moving from 525.00 to 535.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 5.11 and has softened across the 12-week window. Market Dynamics is 0.71 on the latest week. Next-week expectancy is negative at 20.76% based on similar historical setup states.
Industry Peers
Mexico equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| ARDX Ardelyx, Inc. | MEX | 17 Jul 2026 | 99.00 | 99.00 | 99.00 | 99.00 | 0.00% |
| BMRN BioMarin Pharmaceutical Inc. | MEX | 17 Jul 2026 | 959.00 | 959.00 | 959.00 | 959.00 | 0.00% |
| BNTXN BioNTech SE | MEX | 17 Jul 2026 | 1590.00 | 1590.00 | 1590.00 | 1590.00 | 0.00% |
| DNA Ginkgo Bioworks Holdings, Inc. | MEX | 17 Jul 2026 | 170.00 | 170.00 | 170.00 | 170.00 | 0.00% |
| INCY Incyte Corporation | MEX | 17 Jul 2026 | 2067.00 | 2067.00 | 2067.00 | 2067.00 | 0.00% |
| KYNB Kyntra Bio, Inc. | MEX | 17 Jul 2026 | 127.90 | 127.90 | 127.90 | 127.90 | 0.00% |
| REGN Regeneron Pharmaceuticals, Inc. | MEX | 17 Jul 2026 | 10835.99 | 10835.99 | 10835.99 | 10835.99 | 0.00% |
| SMMT Summit Therapeutics Inc. | MEX | 17 Jul 2026 | 290.12 | 290.12 | 290.12 | 290.12 | 0.00% |
| SRPT SAREPTA THERAPEUTICS INC | MEX | 17 Jul 2026 | 294.00 | 294.00 | 294.00 | 294.00 | 0.00% |
| VRTX Vertex Pharmaceuticals Incorporated | MEX | 17 Jul 2026 | 8474.00 | 8474.00 | 8295.00 | 8319.00 | -1.83% |
| CRSPN CRISPR Therapeutics AG | MEX | 17 Jul 2026 | 880.00 | 880.30 | 850.00 | 850.00 | -3.41% |
| INO Inovio Pharmaceuticals, Inc. | MEX | 17 Jul 2026 | 21.26 | 21.26 | 20.00 | 20.00 | -5.93% |
| ALT1 Altimmune, Inc. | MEX | 17 Jul 2026 | 53.40 | 53.40 | 50.09 | 50.09 | -6.20% |
| PROK ProKidney Corp. | MEX | 17 Jul 2026 | 29.50 | 29.50 | 27.50 | 27.59 | -6.47% |
| MRNA Moderna, Inc. | MEX | 17 Jul 2026 | 1195.00 | 1207.00 | 1100.00 | 1100.00 | -7.95% |
| OCGN Ocugen, Inc. | MEX | 17 Jul 2026 | 26.00 | 26.00 | 23.88 | 23.88 | -8.15% |